Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Conference Roundup > Study compares minimally invasive glaucoma surgeries: time, cost, and success rates
  • Conference Roundup

Study compares minimally invasive glaucoma surgeries: time, cost, and success rates

Kelsey Moroz

The different types of minimally invasive glaucoma surgeries (MIGS)—Hydrus, iStent, Kahook Dual Blade (KDB), and OMNI—have similar surgery times, costs, and success rates when combined with cataract surgery, according to a poster presented at AAO 2024. The primary cost differences were driven by the price of devices and implants, rather than the surgical procedures themselves.

Conducted at a single academic center, the study involved 262 cases utilizing 4 MIGS techniques: Hydrus, iStent, Kahook Dual Blade (KDB), and OMNI.

There were no significant differences in surgery times between iStent and Hydrus (20.51 vs 20.70 minutes) or between KDB and OMNI (21.67 vs 18.14 minutes). Cost comparisons showed little variation, with iStent and Hydrus procedures costing $1,389 and $1,433, respectively, and KDB and OMNI costing $1,434 and $1,385.

Approximately 78% of the cases were deemed successful, with no statistically significant differences in success rates across the different MIGS types.

Reference
Flaharty K, et al. A Time-Driven Activity-Based Cost Analysis of MIGS. Poster presented at: American Academy of Ophthalmology Annual Meeting; October 2024; Chicago.

Share

Related Content

  • Glaucoma

Geographic differences in glaucoma care raise concerns about equitable access

  • Glaucoma

Study finds significant IOP reductions with iDose TR and MIGS procedures

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

  • Glaucoma

GLP-1 therapies may offer potential benefits in glaucoma

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Glaucoma

iStent adoption rises as surgeons treat glaucoma earlier

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon